Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.

A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the ...

Chandigarh: After standoffs over funding in recent years, the Union ministry of health and family welfare approved ...

In a case of serious medical error, an 18-year-old man was treated for six months for tuberculosis (TB) when he actually had ...

Bacille Calmette-Guérin revaccination shows no efficacy in preventing sustained Mycobacterium tuberculosis infection compared with placebo in adolescents in a phase 2b study.

No fewer than 50,000 Nigerians have tested positive for tuberculosis, following the increased screening efforts nationwide, Global Fund, an international NGO has said.The Fund, however, said that many ...

However, infectious diseases that were hitherto under control are re-emerging globally and the pathogens of these diseases are highly resistant to known antibiotics.

Background: Tuberculosis (TB) is a major global health threat, with Ningbo reporting over 3,000 annual cases of pulmonary tuberculosis (PTB). This study analyzes the notification and mortality rates ...

Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB ...

The story of Fimbrion is a footnote in the much larger story of this president’s determination to withdraw the federal ...

Delayed sputum conversion and high treatment failure are common in patients with bedaquiline-resistant TB, urging faster ...

If you’re only looking inward, what might you be missing? Learn why understanding how others see you and being open to ...